Finny Kuruvilla from Eventide Asset Management discusses the dynamic biotech and healthcare markets. He highlights how recent breakthroughs in Alzheimer’s treatment and cancer screening are reshaping patient care. The conversation touches on the challenges of navigating private and public biotech markets, driven by venture capital dynamics. Kuruvilla also explores AI's role in enhancing healthcare diagnostics and decision-making. Throughout, he emphasizes the intersection of faith and investment, advocating for ethical choices that promote human flourishing.